SEC Form 4 · accession 0001182489-18-000322
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Turitz
Officer — SVP - Business Development
Period of report
Sep 4, 2018
Accepted (ET)
Sep 5, 2018 · 1:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 4, 2018 | M | 8,202 | $6.01 | A | 9,378 | D | |
| Common StockF2 | Sep 4, 2018 | S | 8,202 | $77.42 | D | 1,176 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $6.01 | Sep 4, 2018 | M | 8,202 | D | — | Dec 18, 2024 | Common Stock | 8,202 | 10,936 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018.
- F2Represents the weighted average price of transactions ranging from $77.15 to $77.60. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The option vests as to 25% of the shares on December 18, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.